For years, Roche has been increasing medicine production in the United States. That could pay off for the drug maker as ...

Roche has become the latest major drugmaker to announce a significant investment in the US, committing $50bn into the country ...

Roche is set to invest $50bn in pharmaceuticals and diagnostics in the US over the coming five years to bolster its presence ...

Roche will add more than 12,000 new jobs as it grows its U.S. operations with new and upgraded production and research sites.

Roche is committing $50 billion over the next five years for new research and development sites across the country, and the pharmaceutical company has their eyes on Indiana. Roche, a Swiss company, ...

Roche said it will expand existing sites and construct new U.S. manufacturing and R&D infrastructure in areas such as gene ...

Executives at some of the world's biggest companies are faced with the tricky task of explaining how President Donald Trump's ...

Swiss pharmaceutical leader Roche revealed on Tuesday its intention to allocate USD50 billion in the United States for ...

Major pharmaceutical companies are committing billions to US manufacturing in an effort to avoid steep tariffs threatened by ...

The Swiss pharma giant made one of the most significant financial promises to bolster its domestic manufacturing capabilities as the Trump administration weighs levying tariffs on drugmakers.

President Trump wants to bring manufacturing back to the U.S. These companies say they're investing in domestic factories.

Wall Street powered to its second-best weekly advance of 2025 on Friday, with the benchmark S&P 500 (SP500) jumping nearly 5%. For the week, the S&P advanced +4 ...